Amyloid Beta And Tau As Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies
…these technologies to advance Aβ and tau as blood-based biomarkers for AD requires further validation using already collected large sets of samples, as well as new cohorts and population-based longitudinal…
read more